News

News


Cresset and Optibrium Announce Technology Collaboration

04 January 2012

Cambridge, and Welwyn Garden City, UK, (January 4th, 2012) – Innovative software and services provider Cresset, and  Optibrium, a provider of software solutions for drug discovery, today announce an agreement to collaborate on the development of next-generation platforms. The innovative companies will work together, combining unique approaches to help drug discovery projects quickly identify novel, [...]

Read Article


Cresset Announces the Release of FieldStere V3.0

01 November 2011

Welwyn Garden City, UK (1st Nov 2011) Cresset is pleased to announce the release of a new version of popular bioisostere replacement tool, FieldStere.  FieldStere is a fast and powerful software tool which uses Cresset’s innovative field-point technology, together with a database of molecular fragments, to help guide drug discovery projects and generate new intellectual [...]

Read Article


Cresset Establishes Professional Services Division

06 September 2011

Welwyn Garden City – Cresset is delighted to announce the establishment of a new Professional Services division and the appointment of Dr Martin Slater as its new Director of Consulting.  Martin joins Cresset from BioFocus where, as Senior Research Fellow, he underpinned the SoftFocus library brand with the development of innovative chemogenomic tools and the [...]

Read Article


Design a Molecule: Competition Now Open

26 August 2011

UPDATE: This competition ended September 30th, 2011 and is now closed to new entries. We will be running another one soon so why not sign up for our newsletter to get a head start? Competition Details The contest will run in association with the Fall ACS, the MGMS meeting for Andy Vinter and the Cresset [...]

Read Article


Cresset and Redx Pharma announce Major Drug Discovery Collaboration

25 August 2011

Welwyn Garden City, UK (24th Aug 2011) – Cresset and Redx Pharma are pleased to announce that they have signed a major drug discovery collaboration. The collaboration gives Redx Pharma access to Cresset’s publicly available and proprietary computational chemistry technologies for use on their portfolio of drug discovery programs. In addition Cresset will provide consulting [...]

Read Article